Resources

This report details the findings of a comparative analysis of existing hepatitis B/C testing guidelines and available data on the prevalence and incidence of HBV and HCV among at-risk population groups in EU/EEA countries, to outline the key at-risk groups for hepatitis B and C in EU and EEA countires.

This independent clinical review commissioned by the Scottish Government assesses the impacts of chronic hepatitis C infection on the health and wellbeing of individuals affected by contaminated blood and blood products. The review recommends that Scottish Infected Blood Support Scheme beneficiaries should be able to self-assess regarding the effect hepatitis C has had on their life, and which level of payment they are entitled to as a result. In October 2018, the Scottish Government confirmed it would accept the recommendations of this report.

This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Maidstone on 5th September 2018. The report includes summaries of the workshops held on the day and attendees' reflections and pledges for action.

This HCV Action good practice case study focuses on Edinburgh Access Practice's outreach service, offering testing and treatment for hepatitis C to the homeless population. In the period from March 2014 to December 2016, of the 80 referrals received, 59 patients attended (70%) and 25 started treatment, compared with typical hospital clinical attendance rates of 30-50%. From January 2017 to June 2018 use of DAAs have enabled a further 52 patients to receive treatment at the EAP over the course of just 18 months.